Letter to the Editor
Immunotherapy rechallenge in patients with non-small-cell lung cancer
Read
6615
Timeswas read the article
2253
Total PDF
4362
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 41 | 17 | 58 |
| 2024 November | 73 | 41 | 114 |
| 2024 October | 55 | 34 | 89 |
| 2024 September | 51 | 26 | 77 |
| 2024 August | 65 | 42 | 107 |
| 2024 July | 50 | 30 | 80 |
| 2024 June | 54 | 32 | 86 |
| 2024 May | 65 | 34 | 99 |
| 2024 April | 42 | 36 | 78 |
| 2024 March | 67 | 31 | 98 |
| 2024 February | 43 | 23 | 66 |
| 2024 January | 43 | 24 | 67 |
| 2023 December | 44 | 27 | 71 |
| 2023 November | 64 | 49 | 113 |
| 2023 October | 59 | 44 | 103 |
| 2023 September | 45 | 34 | 79 |
| 2023 August | 48 | 26 | 74 |
| 2023 July | 46 | 33 | 79 |
| 2023 June | 33 | 17 | 50 |
| 2023 May | 61 | 27 | 88 |
| 2023 April | 80 | 18 | 98 |
| 2023 March | 123 | 21 | 144 |
| 2023 February | 61 | 26 | 87 |
| 2023 January | 51 | 24 | 75 |
| 2022 December | 93 | 36 | 129 |
| 2022 November | 89 | 36 | 125 |
| 2022 October | 137 | 41 | 178 |
| 2022 September | 83 | 51 | 134 |
| 2022 August | 102 | 36 | 138 |
| 2022 July | 119 | 52 | 171 |
| 2022 June | 74 | 30 | 104 |
| 2022 May | 90 | 37 | 127 |
| 2022 April | 77 | 37 | 114 |
| 2022 March | 101 | 45 | 146 |
| 2022 February | 84 | 50 | 134 |
| 2022 January | 64 | 59 | 123 |
| 2021 December | 73 | 39 | 112 |
| 2021 November | 70 | 44 | 114 |
| 2021 October | 51 | 52 | 103 |
| 2021 September | 80 | 47 | 127 |
| 2021 August | 55 | 56 | 111 |
| 2021 July | 44 | 26 | 70 |
| 2021 June | 72 | 31 | 103 |
| 2021 May | 71 | 50 | 121 |
| 2021 April | 226 | 124 | 350 |
| 2021 March | 150 | 56 | 206 |
| 2021 February | 107 | 43 | 150 |
| 2021 January | 76 | 36 | 112 |
| 2020 December | 99 | 61 | 160 |
| 2020 November | 79 | 28 | 107 |
| 2020 October | 87 | 37 | 124 |
| 2020 September | 87 | 55 | 142 |
| 2020 August | 148 | 65 | 213 |
| 2020 July | 162 | 111 | 273 |
| 2020 June | 76 | 31 | 107 |
| 2020 May | 68 | 31 | 99 |
| 2020 April | 4 | 4 | 8 |
Show all
